Crunching the numbers for EYPT... Refresh in a moment for the full analysis.
EyePoint, Inc. (EYPT)
Healthcare
mixed
$14.19
Updated: 2026-04-13
48
TradeApes Score
hold
Financial Strength
50
Mixed
Operating Trend
30
Weak
Valuation
60
Healthy
Capital Allocation
30
Weak
Risk
80
Strong
Key Findings
+
Historically cheap — EV/EBITDA in bottom 25% of its 5-year range
−
Excessive stock comp — SBC above 15% of revenue, wealth transfer to employees
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Add to Watchlist
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.